180 related articles for article (PubMed ID: 11886975)
1. Etanercept in four children with therapy-resistant systemic juvenile idiopathic arthritis.
ten Cate R; van Suijlekom-Smit LW; Brinkman DM; Bekkering WP; Jansen-van Wijngaarden CJ; Vossen JM
Rheumatology (Oxford); 2002 Feb; 41(2):228-9. PubMed ID: 11886975
[No Abstract] [Full Text] [Related]
2. Drug-induced systemic lupus erythematosus associated with etanercept therapy in a child with juvenile idiopathic arthritis.
Lepore L; Marchetti F; Facchini S; Leone V; Ventura A
Clin Exp Rheumatol; 2003; 21(2):276-7. PubMed ID: 12747299
[No Abstract] [Full Text] [Related]
3. Etanercept improves active polyarticular juvenile rheumatoid arthritis.
Martini A
Clin Exp Rheumatol; 2001; 19(2):122-4. PubMed ID: 11326472
[No Abstract] [Full Text] [Related]
4. Response to etanercept in juvenile idiopathic arthritis.
Pang H; Wu XH; Xu JZ
JAMA; 2012 Mar; 307(11):1140; author reply 1140-1. PubMed ID: 22436950
[No Abstract] [Full Text] [Related]
5. A systematic review of effectiveness and economic evaluation of new drug treatments for juvenile idiopathic arthritis: etanercept.
Cummins C; Connock M; Fry-Smith A; Burls A
Health Technol Assess; 2002; 6(17):1-43. PubMed ID: 12234456
[No Abstract] [Full Text] [Related]
6. [Application of etanercept in treatment of juvenile idiopathic arthritis and adult onset still disease].
Lewicki M; Kotulska A; Kucharz EJ
Pol Arch Med Wewn; 2005 May; 113(5):505-8. PubMed ID: 16479836
[No Abstract] [Full Text] [Related]
7. Safety and efficacy of once-weekly application of Etanercept in children with juvenile idiopathic arthritis.
Kuemmerle-Deschner JB; Horneff G
Rheumatol Int; 2007 Dec; 28(2):153-6. PubMed ID: 17641897
[TBL] [Abstract][Full Text] [Related]
8. Radiologic Improvement of juvenile idiopathic arthritis-enthesitis-related arthritis following anti-tumor necrosis factor-alpha blockade with etanercept.
Tse SM; Laxer RM; Babyn PS; Doria AS
J Rheumatol; 2006 Jun; 33(6):1186-8. PubMed ID: 16755667
[TBL] [Abstract][Full Text] [Related]
9. Switching the therapy from etanercept to infliximab in a child with rheumatoid factor positive polyarticular juvenile idiopathic arthritis.
Nerome Y; Imanaka H; Nonaka Y; Takei S
Mod Rheumatol; 2007; 17(6):526-8. PubMed ID: 18084710
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan.
Mori M; Takei S; Imagawa T; Imanaka H; Nerome Y; Higuchi R; Kawano Y; Yokota S; Sugiyama N; Yuasa H; Fletcher T; Wajdula JS
Mod Rheumatol; 2012 Sep; 22(5):720-6. PubMed ID: 22212889
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with treatment response to etanercept in juvenile idiopathic arthritis.
Otten MH; Prince FH; Armbrust W; ten Cate R; Hoppenreijs EP; Twilt M; Koopman-Keemink Y; Gorter SL; Dolman KM; Swart JF; van den Berg JM; Wulffraat NM; van Rossum MA; van Suijlekom-Smit LW
JAMA; 2011 Dec; 306(21):2340-7. PubMed ID: 22056397
[TBL] [Abstract][Full Text] [Related]
12. [Recommendations by the Pediatric and Adolescent Rheumatology Study Committee on therapy with Etanercept (p75 TNF-alpha receptor immunoglobulin fusion protein. Pharmacotherapy Committee].
Horneff G; Forster J; Seyberth HW; Michels H;
Z Rheumatol; 2000 Dec; 59(6):365-9. PubMed ID: 11201000
[No Abstract] [Full Text] [Related]
13. The TREAT study - trial or tribulation?
Lehman TJ
J Rheumatol; 2014 Jun; 41(6):1038-9. PubMed ID: 24882847
[No Abstract] [Full Text] [Related]
14. Good results from combining etanercept to prevailing DMARD therapy in refractory juvenile idiopathic arthritis.
Haapasaari J; Kautiainen H; Hannula S; Pohjankoski H; Hakala M
Clin Exp Rheumatol; 2002; 20(6):867-70. PubMed ID: 12508784
[TBL] [Abstract][Full Text] [Related]
15. Crohn's disease in a patient with juvenile idiopathic arthritis after starting etanercept therapy - causal link or only temporal coincidence?
Flemming GM; Tóth G; Gebauer C; Schuster V
Klin Padiatr; 2013 Nov; 225(6):350-1. PubMed ID: 24166091
[No Abstract] [Full Text] [Related]
16. A combination of etanercept and methotrexate for the treatment of refractory juvenile idiopathic arthritis: a pilot study.
Schmeling H; Mathony K; John V; Keysser G; Burdach S; Horneff G
Ann Rheum Dis; 2001 Apr; 60(4):410-2. PubMed ID: 11247875
[TBL] [Abstract][Full Text] [Related]
17. Trials reveal promising options for treating juvenile rheumatoid arthritis.
Hampton T
JAMA; 2008 Jan; 299(1):27-8. PubMed ID: 18167400
[No Abstract] [Full Text] [Related]
18. Medically Significant Infections Are Increased in Patients With Juvenile Idiopathic Arthritis Treated With Etanercept: Results From the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study.
Davies R; Southwood TR; Kearsley-Fleet L; Lunt M; Hyrich KL;
Arthritis Rheumatol; 2015 Sep; 67(9):2487-94. PubMed ID: 25989609
[TBL] [Abstract][Full Text] [Related]
19. Granulomatous disease in a child treated with etanercept.
Alhajri M; Aljumaah S; Aleyouni Y; Al-Qahtani F; Alhazzaa S; Al-Mayouf SM
Int J Rheum Dis; 2013 Aug; 16(4):472-4. PubMed ID: 23826822
[No Abstract] [Full Text] [Related]
20. Improvement of functional ability in children with juvenile idiopathic arthritis by treatment with etanercept.
Halbig M; Horneff G
Rheumatol Int; 2009 Dec; 30(2):229-38. PubMed ID: 19449011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]